Carter Bankshares (CARE) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
4 Aug, 2025Executive summary
Net income for Q2 2025 was $8.5 million and $17.5 million for the first half, up from $4.8 million and $10.6 million year-over-year, driven by higher net interest income and recoveries in credit losses.
Net interest income increased 15.2% year-over-year to $32.4 million for Q2 2025, with net interest margin (FTE) rising to 2.82%.
The company completed the acquisition of two North Carolina branches, adding $55.9 million in deposits and 10 associates.
Announced a $20 million stock repurchase program, with $9.1 million (547,332 shares) repurchased by June 30, 2025.
Nonperforming loans decreased by $8.8 million to $250.6 million, mainly due to curtailment payments on the largest credit relationship.
Financial highlights
Total assets reached $4.8 billion, with portfolio loans up $122.3 million (6.8% annualized) and deposits up $68.8 million (3.3% annualized) since year-end 2024.
Allowance for credit losses to total loans was 1.90% at June 30, 2025, down from 2.72% a year ago.
Noninterest income decreased $0.6 million (11.3%) for Q2 but increased $1.2 million (11.6%) for the first half, aided by a $1.9 million BOLI death benefit.
Noninterest expense rose $1.9 million (6.8%) for Q2 and $3.6 million (6.8%) for the first half, driven by higher occupancy, professional fees, and other expenses.
Diluted EPS was $0.37 for Q2 and $0.76 for the first half, up from $0.21 and $0.46 year-over-year.
Outlook and guidance
Management expects continued loan growth, margin expansion, and a healthy loan pipeline, with benefits anticipated from prior construction lending over the next 12–18 months.
The balance sheet remains liability sensitive, positioning for potential net interest income increases if rates decline.
Focus remains on resolving the large nonperforming credit relationship to protect long-term shareholder value.
Latest events from Carter Bankshares
- Net income and assets grew in 2025, with strong capital, liquidity, and improved margins.CARE
Q4 20255 Feb 2026 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG efforts.CARE
Proxy Filing2 Dec 2025 - Loan and net interest income growth offset by asset quality pressures from a large nonaccrual loan.CARE
Q3 202521 Nov 2025 - Q3 net income increased, margins improved, and major litigation was resolved.CARE
Q3 202413 Jun 2025 - Net income fell as a large NPL persisted, but capital and liquidity remain strong.CARE
Q2 202413 Jun 2025 - Q1 2025 net income surged 55% year-over-year, with strong capital and loan growth.CARE
Q1 20256 Jun 2025 - Q4 net income up, asset quality improved, but large nonperforming loan still weighs on results.CARE
Q4 20245 Jun 2025